Johnson & Johnson, employing approximately 110,600 people worldwide, is engaged
in the manufacture and sale of a broad range of products in the health care field.
Through over 200 operating companies, it conducts business in virtually all countries
of the world. Johnson & Johnson's primary interest, both historically and
currently, has been in products related to human health and well-being. Johnson
& Johnson was organized in the State of New Jersey in 1887.
Johnson & Johnson is organized on the principle of decentralized management.
The Executive Committee of Johnson & Johnson is the principal management
group responsible for the operations and allocation of the resources of the
Company. This Committee oversees and coordinates the activities of the Consumer,
Pharmaceutical and Medical Devices and Diagnostics business segments. Each subsidiary
within the business segments is, with some exceptions, managed by citizens of
the country in which it is located.
Johnson & Johnson's worldwide business is divided into three segments:
Consumer, Pharmaceutical and Medical Devices and Diagnostics.
CONSUMER
The Consumer segment manufactures and markets a broad range of products used
in the baby and child care, skin care, oral and wound care and women's health
care fields, as well as nutritional and over-the-counter pharmaceutical products.
PHARMACEUTICAL
The Pharmaceutical segment's principal worldwide franchises are in the antifungal,
anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal,
hematology, immunology, neurology, oncology, pain management, psychotropic (central
nervous system) and urology fields.
MEDICAL DEVICES AND DIAGNOSTICS
The Medical Devices and Diagnostics segment includes a broad range of products
used by or under the direction of physicians, nurses, therapists, hospitals,
diagnostic laboratories and clinics.
The international business of Johnson & Johnson is conducted by subsidiaries
located in 56 countries outside the United States, which are selling products
in virtually all countries throughout the world.
COMPETITION
In all their product lines, Johnson & Johnson companies compete with companies
both large and small, located in the United States and abroad. Competition is
strong in all lines without regard to the number and size of the competing companies
involved. Competition in research, involving the development of new products
and processes and the improvement of existing products and processes, is particularly
significant and results from time to time in product and process obsolescence.
The development of new and improved products is important to Johnson & Johnson's
success in all areas of its business.
23.13% 
3.06 %